ANI PHARMACEUTICALS, INC Deferred Tax Liabilities, Net
ANI PHARMACEUTICALS, INC (ANIP) had Deferred Tax Liabilities, Net of $100.00 thousand as of 2019-01-31, per its 10-Q filed 2019-11-06.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities
us-gaap:DeferredTaxLiabilities · last filed 2020-02-27
- 2019-01-31: Deferred Tax Liabilities, Net $100.00K.
- 2019-01-01: Deferred Tax Liabilities, Net $100.00K.
| Period end | Deferred Tax Liabilities, Net |
|---|---|
| 2019-01-31 | $100.00K 10-Q · filed 2019-11-06 |
| 2019-01-01 | $100.00K 10-K · filed 2020-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |